REGULATED INFORMATION The autoimmune disease platform has completed a successful phase IIb trial targeting cGVHD (chronic Graft vs Host Disease), with a.
PRESS RELEASE - INSIDE INFORMATION Recent medical publications provide new insights in timing and dynamics of fracture healing using early radiological.
REGULATED INFORMATION Preliminary documents for the Extraordinary General Meeting have been made available on company’s website Mont-Saint-Guibert, Belgium, 13 June 2022, 7am CEST. | June 13, 2022